SEC 13F Intelligence

Amova Asset Management Americas, Inc. / TXG

Amova Asset Management Americas, Inc.’s 10x Genomics Inc Position

Does Amova Asset Management Americas, Inc. own 10x Genomics Inc (TXG)? Yes5.10M shares worth $108M (+1.53% of its 13F portfolio) as of Q1 2026, down from 5.49M shares the prior filed quarter.

Position Value
$108M
Q1 2026
Shares
5.10M
% of Portfolio
+1.53%
Quarters Held
24
currently held

Position History TXG

Reported value by quarter
Q2 ’20: $18MQ2 ’20Q3 ’20: $12MQ4 ’20: $17MQ1 ’21: $189MQ1 ’21Q2 ’21: $299MQ3 ’21: $192MQ4 ’21: $166MQ4 ’21Q1 ’22: $109MQ2 ’22: $57MQ3 ’22: $61MQ3 ’22Q4 ’22: $79MQ1 ’23: $110MQ2 ’23: $99MQ2 ’23Q3 ’23: $71MQ4 ’23: $128MQ1 ’24: $136MQ1 ’24Q2 ’24: $119MQ3 ’24: $144MQ4 ’24: $82MQ4 ’24Q1 ’25: $47MQ2 ’25: $70MQ3 ’25: $63MQ3 ’25Q4 ’25: $89MQ1 ’26: $108Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20265.10M$108M+1.53%
Q4 20255.49M$89M+1.03%
Q3 20255.38M$63M+0.61%
Q2 20256.01M$70M+0.69%
Q1 20255.36M$47M+0.60%
Q4 20245.71M$82M+0.89%
Q3 20246.37M$144M+1.63%
Q2 20246.15M$119M+1.38%
Q1 20243.62M$136M+1.35%
Q4 20232.28M$128M+1.23%
Q3 20231.72M$71M+0.85%
Q2 20231.77M$99M+1.04%
Q1 20232.02M$110M+1.26%
Q4 20222.18M$79M+1.14%
Q3 20222.21M$61M+0.78%
Q2 20221.41M$57M+0.70%
Q1 20221.43M$109M+0.80%
Q4 20211.25M$166M+0.87%
Q3 20211.33M$192M+0.82%
Q2 20211.54M$299M+1.17%
Q1 20211.04M$189M+0.92%
Q4 2020118.4K$17M+0.10%
Q3 2020102.3K$12M+0.11%
Q2 2020206.2K$18M+0.23%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Amova Asset Management Americas, Inc.’s full portfolio or all institutional holders of TXG.